Results suggest that the release of bFGF following cell death contributes to enhanced chemosensitivity in Non-Small-Cell lung Carcinoma (NSCLC) cell lines.

endogenously synthesized fibrinogen promotes the growth of lung and prostate cancer cells through interaction with FGF-2.

bFGF, FGFR1, and FGFR2 are frequently overexpressed in squamous cell carcinoma and adenocarcinoma of the lung and may have a role in neoplasm pathogenesis

High tumor cell FGF2 expression is associated with non-small cell lung cancer.

Serum CEA, SCCA and bFGF joint detection improved detection sensitivity in lung cancer and had important reference value for pathological type deduction.

Suggest that miR-195, a tumor suppressor miRNA, contributes to the lung metastasis of HCC by negatively regulating FGF2 and VEGFA expression.

BFGF overexpression is a potential indicator of worse prognosis for patients with operable non-small- and small- cell lung carcinomas. (Meta-analysis)

High FGF2 expression is associated with lung cancer.